IBRX Sale Disclosure
Cohen Cheryl · SEC Form 4 · Filed Oct 6, 2026
Sale
Calculated transaction value
$851.09K
Cohen Cheryl Director
IBRX
ImmunityBio
IBRX
Transaction date
Oct 2, 2026
Public filing date
Oct 6, 2026
Filing lag
Filed 4 days later
IBRX daily price context
Close on/before transaction
$10.29
Oct 2, 2026
First close after public filing
$9.75
Oct 7, 2026
Return after filing · so far
+3.79%
Through Oct 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 81,056 shares @ $10.5
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001326110-26-000084
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.02M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Immunitybio, Inc. IBRX | Exercise | Oct 2, 2026 | $166.82K |
| Immunitybio, Inc. IBRX | Exercise | Oct 2, 2026 | $0 |
| Immunitybio, Inc. IBRX Current | Sale | Oct 2, 2026 | $851.09K |